NS053454/NS/NINDS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	2
2009	2
2010	5
2011	1
2012	3
2013	1
2015	2
2024	0

1

Nanotechnology applications for glioblastoma.

Nduom EK, Bouras A, Kaluzova M, Hadjipanayis CG. Nduom EK, et al. Neurosurg Clin N Am. 2012 Jul;23(3):439-49. doi: 10.1016/j.nec.2012.04.006. Epub 2012 Jun 14. Neurosurg Clin N Am. 2012. PMID: 22748656 Free PMC article. Review.

2

Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy.

Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Wankhede M, et al. Expert Rev Clin Pharmacol. 2012 Mar;5(2):173-86. doi: 10.1586/ecp.12.1. Expert Rev Clin Pharmacol. 2012. PMID: 22390560 Free PMC article. Review.

3

Brain cancer propagating cells: biology, genetics and targeted therapies.

Hadjipanayis CG, Van Meir EG. Hadjipanayis CG, et al. Trends Mol Med. 2009 Nov;15(11):519-30. doi: 10.1016/j.molmed.2009.09.003. Epub 2009 Nov 2. Trends Mol Med. 2009. PMID: 19889578 Free PMC article. Review.

4

Tumor initiating cells in malignant gliomas: biology and implications for therapy.

Hadjipanayis CG, Van Meir EG. Hadjipanayis CG, et al. J Mol Med (Berl). 2009 Apr;87(4):363-74. doi: 10.1007/s00109-009-0440-9. Epub 2009 Feb 3. J Mol Med (Berl). 2009. PMID: 19189072 Free PMC article. Review.

5

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Van Meir EG, et al. CA Cancer J Clin. 2010 May-Jun;60(3):166-93. doi: 10.3322/caac.20069. CA Cancer J Clin. 2010. PMID: 20445000 Free PMC article. Review.

6

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.

Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG. Kaluzova M, et al. Oncotarget. 2015 Apr 20;6(11):8788-806. doi: 10.18632/oncotarget.3554. Oncotarget. 2015. PMID: 25871395 Free PMC article.

7

Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.

Bouras A, Kaluzova M, Hadjipanayis CG. Bouras A, et al. J Neurooncol. 2015 Aug;124(1):13-22. doi: 10.1007/s11060-015-1807-0. Epub 2015 May 17. J Neurooncol. 2015. PMID: 25981803 Free PMC article.

8

Full scope of options.

Hadjipanayis CG, Schuette AJ, Boulis N, Hao C, Barrow DL, Teo C. Hadjipanayis CG, et al. Neurosurgery. 2010 Jul;67(1):197-203; discussion 203-4. doi: 10.1227/01.NEU.0000370602.15820.E4. Neurosurgery. 2010. PMID: 20559107 Free PMC article.

9

Canine model of convection-enhanced delivery of cetuximab-conjugated iron-oxide nanoparticles monitored with magnetic resonance imaging.

Platt S, Nduom E, Kent M, Freeman C, Machaidze R, Kaluzova M, Wang L, Mao H, Hadjipanayis CG. Platt S, et al. Clin Neurosurg. 2012;59:107-13. doi: 10.1227/NEU.0b013e31826989ef. Clin Neurosurg. 2012. PMID: 22960522 Free PMC article.

10

Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening.

Hadjipanayis CG, Jiang H, Roberts DW, Yang L. Hadjipanayis CG, et al. Semin Oncol. 2011 Feb;38(1):109-18. doi: 10.1053/j.seminoncol.2010.11.008. Semin Oncol. 2011. PMID: 21362519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year